Elanco Animal Health Incorporated (ELAN) Growth Rates Comparisons to Major Pharmaceutical Preparations Industry, Sector, Market. Sales, Income, EPS
CSIMarket Company Name, Ticker, Competitors, else..
 
Elanco Animal Health Incorporated  (NYSE: ELAN)
 

Elanco Animal Health Incorporated Growth Comparisons

Select each growth Category to receive further Information




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ELAN Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q2 MRQ) 10.23 % 12.24 % 9.19 % 10.9 %
Q / Q Revenue Growth (Q2 MRQ) -0.22 % -2.93 % -3.28 % 8.32 %
Y / Y Revenue Growth (for 12 months ending Q2 TTM) 11.95 % 9.25 % 7.99 % %
Sequential Revenue Growth (for 12 months ending Q2 TTM) 2.6 % 2.69 % 2.09 % 2.61 %
Revenue 5 Year Average Growth 7.57 % 7.41 % 8.65 % 10.59 %


ELAN's Growth Comparisons in II. Quarter 2026




Elanco Animal Health Incorporated's 10.23% year on year Revenue increase in the second quarter 2026 to 1.37 billions, marks slow-down from Elanco Animal Health Incorporated's growth trends, and competes unfavorably to the 12.24% rise in the Major Pharmaceutical Preparations industry, but beating the 9.19% growth in the Healthcare sector. Comparing the second quarter sales, Elanco Animal Health Incorporated was trailing overall market not just the Major Pharmaceutical Preparations industry.

Top-line fell by -0.22% from the first quarter. Average annual sales growth for Elanco Animal Health Incorporated is 7.57%, while S & P 500's average yearly sales increase is 10.59%, including only Businesses with the second quarter 2026 financial results.

ELAN Growth Rates by Company's Segments

Segment Name
Y / Y
Sequential
Pet Health
-
101.13 %
Cattle
-
99.05 %
Poultry
-
96.96 %
Swine
-
101.04 %
Farm Animal
-
98.6 %
Contract Manufacturing
-
-
United States
-
109.59 %
Non-US
-
-
Reportable
-
-
Total
10.23 %
-0.22 %


Growth Rates of ELAN's Income in the second quarter 2026


ELAN Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q2 MRQ) - -8.69 % 5.13 % 97.6 %
Sequential Operating Income Change (Q2 MRQ) - -4.52 % 0.89 % 48.13 %
Y / Y Operating Income Growth (Q2 TTM) - 30.72 % 30.96 % 40.67 %
Sequential Operating Income Growth (Q2 TTM) - -2.28 % 4.91 % 20.86 %
Operating Income 5 Year Avg. Change - 14.39 % 10.39 % 18.76 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q2 MRQ) 390.91 % -34.78 % -25.81 % 90.69 %
Sequential Income from Cont. Ops. Change (Q2 MRQ) -5.26 % -2.61 % -66.16 % 27.07 %
Y / Y Income from Cont. Ops. Change (Q2 TTM) - 6.22 % 9.85 % 57.33 %
Sequential Income from Cont. Ops. Change (Q2 TTM) - -10.03 % -4.69 % 18.65 %
Income from Cont. Ops. 5 Year Avg. Change - -0.55 % 0.17 % -28.52 %

ELAN Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q2 MRQ) 390.91 % -35.13 % -26.29 % 90.69 %
Q / Q Net Income Growth (Q2 MRQ) -5.26 % 2.8 % -0.86 % 27.07 %
Y / Y Net Income Change (Q2 TTM) - 5.2 % 15.48 % 57.33 %
Sequential Net Income Change (Q2 TTM) - -10.18 % -6.71 % 18.65 %
Net Income 5 Year Avg. Growth - 14.55 % 9.21 % 22.96 %

ELAN's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q2 MRQ) 450 % -40.16 % -25.81 % 90.69 %
Sequential EPS from Cont. Ops. Change (Q2 MRQ) 0 % -7.73 % -66.16 % 27.07 %
Y / Y EPS from Cont. Ops. Change (Q2 TTM) - - - -
Sequential EPS from Cont. Ops. Change (Q2 TTM) - - - 4.88 %
EPS from Cont. Ops. 5 Year Avg. Growth - -10.79 % 0.17 % -28.52 %



ELAN EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q2 MRQ) 450 % -40.49 % -26.29 % -28.52 %
Q / Q EPS Net Growth (Q2 MRQ) 0 % -2.61 % -0.86 % 27.07 %
Y / Y EPS Net Change (for 12 months ending Q2 TTM) - - - 7.62 %
Sequential EPS Net Change (for 12 months ending Q2 TTM) - -7.05 % -4.12 % 4.93 %
EPS Net 5 Year Avg. Change - 14.55 % 9.21 % 22.96 %



Despite the -40.49% decline in Major Pharmaceutical Preparations industry, Elanco Animal Health Incorporated showed impressive surge in EPS in the second quarter by 450% from the same quarter a year ago, to $0.11, Healthcare sector dropped -26.29%. Despite modest earnings per share in the Major Pharmaceutical Preparations industry and ind the Healthcare sector, Elanco Animal Health Incorporated reported above average market earnings per share growth.

Sequentially company's EPS were unchanged from the first quarter results. . Looking into annual growth, income per share grew by 7.57% on average in the last five years, while the S & P 500's including only the businesses with the second quarter 2026 financial results, average yearly income per share growth is 22.96%.

ELAN Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q2 MRQ) 35.56 % 25.53 % 48.48 % 48.62 %
Sequential Free Cash Flow Change (Q2 MRQ) - -42.35 % -46.96 % 34.18 %
Y / Y Free Cash Flow Change (Q2 TTM) 9.22 % 12.28 % 19.59 % 60.27 %
Sequential Free Cash Flow Change (Q2 TTM) 20.32 % 3.34 % 5.76 % 15.75 %
Free Cash Flow 5 Year Avg. Change - 1.86 % 0.92 % 8.28 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q2 MRQ) - - - 339.02 %
Sequential Net Cash Flow Change (Q2 MRQ) - - - 216.68 %
Y / Y Net Cash Flow Change (Q2 TTM) - - - 209.43 %
Sequential Net Cash Flow Change (Q2 TTM) - - - 152.64 %
Net Cash Flow 5 Year Avg. Change -13.64 % 29.88 % 6.46 % 1.06 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q2 MRQ) -42.11 % 11.25 % 8.23 % 120.03 %
Sequential Capital Expenditures Change (Q2 MRQ) -35.29 % -25.6 % -22.09 % 36.87 %
Y / Y Capital Expenditures Change (Q2 TTM) 5.78 % 16.46 % 7.77 % 109.38 %
Sequential Capital Expenditures Change (Q2 TTM) -9.16 % 2.81 % 1.52 % 23.05 %
Capital Expenditures 5 Year Avg. Change -2.35 % 7.84 % 8.61 % 14.74 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Y/Y Annual




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.